GH Research (GHRS) financial statements

Healthcare · Biotechnology · Market cap $1.5B

Net income was -$48M.

Free cash flow was -$44M.

The diluted share count rose 118% over the period (dilution).

Income statement

Fiscal years, from GH Research's 10-K filings with the SEC.

Fiscal year2019202020212022202320242025
Research and development$296,000$338,000$9M$20M$30M$35M$39M
Selling, general and admin$14,000$108,000$7M$10M$11M$15M$22M
Operating income-$310,000-$446,000-$15M-$31M-$41M-$50M-$61M
Interest expense$0$0$9,000$0$63,000$717,000$463,000
Pre-tax income-$310,000-$446,000-$9M-$22M-$36M-$39M-$48M
Income tax$0$0$0$0$0$0$0
Net income-$310,000-$446,000-$9M-$22M-$36M-$39M-$48M
EPS (diluted)-$0.01-$0.02-$0.21-$0.43-$0.68-$0.75-$0.79
Diluted shares28M28M44M52M52M52M61M

Balance sheet

Fiscal years, from GH Research's 10-K filings with the SEC.

Fiscal year2019202020212022202320242025
Cash and short-term investments$498,000$6M$277M$166M$78M$101M$246M
Total current assets—$6M$280M$169M$164M$154M$286M
Property, plant and equipment—$0$82,000$97,000$1M$748,000$620,000
Total assets—$6M$280M$254M$226M$188M$288M
Total current liabilities—$246,000$3M$5M$7M$9M$8M
Total liabilities—$246,000$3M$5M$7M$9M$9M
Shareholders' equity$400,000$6M$277M$250M$219M$179M$280M
Net debt-$498,000-$6M-$277M-$166M-$78M-$101M-$246M

Cash flow

Fiscal years, from GH Research's 10-K filings with the SEC.

Fiscal year2019202020212022202320242025
Operating cash flow-$289,000-$330,000-$15M-$26M-$33M-$42M-$44M
Capital spending$0$0$104,000$67,000$100,000$49,000$121,000
Free cash flow-$289,000-$330,000-$15M-$26M-$33M-$42M-$44M
Stock-based compensation$0$0$366,000$2M$2M$1M$9M
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for GHRS.
Open GHRS in Investingly

Questions

How much free cash flow does GH Research generate?

-$44M in fiscal 2025 (operating cash flow minus capital spending).

From GH Research's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.